Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.34 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | PPARD | Q03181 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13864868 | 1.00 | PPARA (0.34) | PPARAPPARGPPARDNPC1USP2 | |
| SCHEMBL4381997 | 0.91 | PPARA (0.39) | PPARAPPARGPPARDNPC1USP2 | |
| SCHEMBL4484618 | 0.91 | PPARA (0.39) | PPARAPPARGPPARDNPC1USP2 | |
| SCHEMBL4484621 | 0.91 | PPARA (0.39) | PPARAPPARGPPARDNPC1USP2 | |
| SCHEMBL4472882 | 0.91 | PPARA (0.39) | PPARAPPARGPPARDNPC1USP2 | |
| SCHEMBL4378274 | 0.88 | PPARA (0.36) | PPARAPPARGPPARDNPC1USP2 | |
| SCHEMBL14281494 | 0.82 | PPARG (0.41) | PPARAPPARGPPARDALDH1A1LMNA | |
| SCHEMBL4388960 | 0.81 | PPARG (0.40) | PPARAPPARGPPARD | |
| SCHEMBL4389972 | 0.81 | PPARG (0.40) | PPARAPPARGPPARD | |
| SCHEMBL4483727 | 0.81 | PPARG (0.40) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1789402-B1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-11-18 | — | — | EP | disclosed |